<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01664026</url>
  </required_header>
  <id_info>
    <org_study_id>PWeb123</org_study_id>
    <nct_id>NCT01664026</nct_id>
  </id_info>
  <brief_title>Efficacy of a Web-based Lifestyle Modification Program in Obese Patients With Cardiovascular Risk Factors</brief_title>
  <official_title>A 6-Month, Randomized Study to Evaluate the Efficacy of a Web-based Lifestyle Modification Program With and Without Telephone Counseling Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clínica Bazterrica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clínica Bazterrica</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of a 6-month web-based lifestyle modification program with and without
      telephone counseling versus usual care in obese patients with cardiovascular risk factors on:

        -  Weight Loss

        -  Waist circumference; blood pressure; total cholesterol, triglycerides, LDL-cholesterol,
           HDL-cholesterol; glucose and hemoglobin A1c; C-reactive protein.

        -  Physical activity and eating habits

        -  Quality of life
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in body weight from randomization to 6 months</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in waist circumference</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in blood pressure</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in lipid parameters (total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in glycemic parameters (glucose and hemoglobin A1c)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in C-reactive protein</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes in lifestyle behaviors (physical activity and eating habits)</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes in quality of life</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects assigned to the usual care group will receive general lifestyle recommendations as per their country standards of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Web</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Web+</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Web-based lifestyle modification</intervention_name>
    <description>Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.</description>
    <arm_group_label>Web</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Web-based lifestyle modification +</intervention_name>
    <description>Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.</description>
    <arm_group_label>Web+</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female 25-70 years of age

          2. Obese (BMI ≥ 30 kg/m2 and &lt;40 kg/m2)

          3. At least 2 cardiovascular risk factors (diabetes, hypertension or dyslipidemia) i)
             Hypertension defined by a history of hypertension, treatment of hypertension or BP
             values &gt;140/90 mmHg in two consecutive office visits ii) High cholesterol defined by
             an LDL-C ≥130 mg/dL and/or HDL-C &lt;40 mg/dL and triglycerides ≥150 mg/dL iii) Type 2
             Diabetes Mellitus defined by a history of diabetes, treatment of diabetes or fasting
             glucose ≥126 mg/dL in two consecutive office visits

          4. Participant must be willing and able to provide written informed consent

          5. Participant must be willing and able to comply with study related procedures

          6. Participant must have access to Internet and e-mail

        Exclusion Criteria:

          1. Stage 1 or 2 on Patient Activation Measures tool

          2. Weight change of more than 5 kg during the 3 months preceding the screening visit

          3. History of bariatric surgery

          4. Fasting Plasma Glucose at screening &gt; 250 mg/dL (&gt; 13.9 mmol/L)

          5. Hemoglobin A1c at screening &gt;8.5%

          6. Treatment of type 2 diabetes with insulin (except for history of intermittent acute
             use, no more than 2 weeks usage in previous 6 months)

          7. Uncontrolled or inadequately controlled hypertension at the time of screening with
             blood pressure &gt;160/100 mmHg

          8. Secondary hypertension

          9. Changes in lipid, blood pressure or diabetes modifying agents including introduction,
             change in dose or cessation in the 3 months prior to Screening Visit

         10. Personal history of coronary heart disease, congestive heart failure, serious
             arrhythmias and stroke

         11. Cardiovascular, hepatic, neurological, endocrine disease, active malignant tumor or
             other major systemic disease making implementation of the protocol or interpretation
             of the study results difficult.

         12. Presence of any condition (medical, psychological, social, or geographical), actual or
             anticipated, that in the opinion of the Investigator would restrict or limit the
             patient's successful participation for the duration of the study

         13. Presence of history of cancer within the past five years with the exception of
             adequately treated localized basal cell skin cancer or in situ uterine cervical cancer

         14. Use of systemic glucocorticoids (excluding topical application or inhaled forms) for
             one week or more within 3 months prior to the time of screening

         15. Use of any investigational agent (drug, biologic, device) within 3 months prior to
             screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andres Digenio, MD</last_name>
    <role>Study Director</role>
  </overall_official>
  <location>
    <facility>
      <name>Clinica Bazterrica</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2012</study_first_submitted>
  <study_first_submitted_qc>August 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2012</study_first_posted>
  <last_update_submitted>August 10, 2012</last_update_submitted>
  <last_update_submitted_qc>August 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clínica Bazterrica</investigator_affiliation>
    <investigator_full_name>Arnaldo Angelino</investigator_full_name>
    <investigator_title>Jefe de Prevencion y Rehabilitacion</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

